Michihide Tokuhira, Yuta Kimura, Takayuki Tabayashi, Naoki Watanabe, Shun Tsuchiya, Tomoiku Takaku, Noriyoshi Iriyama, Eriko Sato, Tomonori Nakazato, Toru Mitsumori, et al. Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects. International Journal of Hematology. 2023
Shun Tsuchiya, Tomoiku Takaku, Naoki Watanabe, Noriyoshi Iriyama, Yuta Kimura, Eisaku Iwanaga, Kei-ji Sugimoto, Toru Mitsumori, Maho Ishikawa, Tomonori Nakazato, et al. Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice. Internal Medicine. 2023
Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, et al. Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors. Annals of Medicine. 2022. 54. 1. 1244-1254
Atsushi Marumo, Satoshi Wakita, Kaoru Morita, Iekuni Oh, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, et al. NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia. International Journal of Hematology. 2022. 116. 2. 199-214
高久 智生, 藤岡 功, 入山 規良, 得平 道英, 木村 勇太, 岩永 栄作, 佐藤 恵理子, 石川 真穂, 仲里 朝周, 杉元 啓二, et al. 慢性骨髄性白血病患者のTKI治療における血栓症に関する多施設共同後方視的解析 中間解析アップデート(An updated analysis of vascular adverse events in large cohort of TKI treated Japanese CML patients). 臨床血液. 2018. 59. 9. 1705-1705
I. Fujioka, T. Takaku, N. Iriyama, M. Tokuhira, E. Sato, M. Ishikawa, T. Nakazato, K-J. Sugimoto, H. Fujita, N. Asou, et al. ANALYSIS OF VASCULAR ADVERSE EVENTS IN TKI TREATED JAPANESE CML PATIENTS: RETROSPECTIVE LARGE COHORT STUDY OF CML COOPERATIVE STUDY GROUP. HAEMATOLOGICA. 2017. 102. 435-436